Amerisource Recalls Glipizide Extended-Release Tablets Due to Dissolution Failure
Amerisource Health Services is recalling specific lots of Glipizide Extended-Release tablets because they failed to meet dissolution specifications.
- Product
- GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx Only, Packaged and Distributed by American Health Packaging, Columbus, Ohio 43217, NDC 68084-295-21
- Category
- Drug
- Distribution
- Distributed nationwide